http://www.fda.gov/cder/orange/appendix_a.txt
2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
Pharmaceutical Research and Manufacturers of America
- Auxilium Pharmceuticals Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes Testim none / none male hormone replacement therapy Auxilium Pharmceuticals East Norriton, PA application submitted - Search By...
Pharmaceutical Research and Manufacturers of America
- male hormone replacement therapy Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes Testim none / none male hormone replacement therapy Auxilium Pharmceuticals East Norriton, PA application submitted -...
Prescription and Over-the-Counter Drug Product List: 4/2003
45 -D- XCEL PHARMS 1MG/ML N05929 001 APR CFTG -A- AP + 1MG/ML N05929 001 APR CFTG -A- DIHYDROEROGTAMINE MESYLATE -A- AP PADDOCK 1MG/ML N40475 001 APR 28, 2003 APR NEWA DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE; ORAL -A- TAZTIA XT -A- AB4 ANDRX PHARMS 120MG N75401 001 APR 10, 2003 APR NEWA -A- AB4 180MG N75401 002 APR 10, 2003 APR NEWA -A- AB4 240MG N75401 003 APR 10, 2003 APR...
author: AUTHOR
Prescription and OTC Drug Product List 10/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc
Figure 1 Mean Steady- State Serum Testosterone (± SD) (ng/ dL) Concentrations on Day 30 in Patients Applying Testim Once Daily The average daily testosterone concentration produced by Testim TM 100 mg at Day 30 was 612 (± 286) ng/ dL and by Testim TM 50 mg at Day 30 was 365 (± 187) ng/ dL Table 1: Mean (± ±± ± SD)...
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 15
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 14
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 10
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 9
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 8
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 6
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 4
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 1
author: Eufrecina deGuia
Forum - Read Topic
Peyronie's Disease Patient Discussion Forum - Topic: "Cheap Viagra" - Date: -12/20/2004 11:47:20 AM Name: -j- Notice how at this point in history we think of medical treatment almost exclusively in terms of drugs. I read in the pharmacy literature every month about the tribulations in this industry and it is up and down. Now, they will also not persue a treatment unless their...
Forum - Read Topic
Peyronie's Disease Patient Discussion Forum - Topic: "AA4500" - Date: -12/2/2005 12:50:59 AM Subject: -Reference? Finally, the cure for Peyronie's!! Just google 'clinical trials definitions'. lets hope to see this go somewhere. The value of the agreement is in excess of $3.3 million for process development and clinical lot production through 2006. The decline reflects...
Forum - Read Topic
Dupuytren's Disease Patient Discussion Forum - Topic: "Phase III FDA Proceeding at Stanford" - Date: -6/2/2005 4:25:39 PM Subject: -Phase III FDA Proceeding at Stanford Name: -AMPAD 70- Is Stanford still in the study? Without trials for DC, hand surgeons would be left to work those things out on their own; a risk that many would be unwilling to take. Denkler, we discussed...
Forum - Read Topic
Date: -7/3/2005 8:04:00 PM Subject: -April financials for Auxuliam Name: -Gretz- Since our inception through December 31, 2004, we have spent $25.2 million on Testim, $3.4 million on our androgen replacement and overactive bladder transmucosal films and $5.5 million on AA4500 for Peyronie's and Dupuytren's Diseases. Currently, Testim is marketed, our androgen...
Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 1
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 16
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 13
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 12
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 11
author: Eufrecina deGuia
C:\Data\My Documents\My NDAs\NDA 21454\AP letter.doc page 7
author: Eufrecina deGuia